Boris Calmels

2.0k total citations
78 papers, 1.4k citations indexed

About

Boris Calmels is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Boris Calmels has authored 78 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hematology, 24 papers in Oncology and 20 papers in Immunology. Recurrent topics in Boris Calmels's work include Hematopoietic Stem Cell Transplantation (54 papers), Acute Myeloid Leukemia Research (14 papers) and CAR-T cell therapy research (14 papers). Boris Calmels is often cited by papers focused on Hematopoietic Stem Cell Transplantation (54 papers), Acute Myeloid Leukemia Research (14 papers) and CAR-T cell therapy research (14 papers). Boris Calmels collaborates with scholars based in France, Italy and United States. Boris Calmels's co-authors include Christian Chabannon, Claude Lemarié, Didier Blaise, Cynthia E. Dunbar, Christof von Kalle, Manfred Schmidt, Peiman Hematti, Rima Adler, Stephanie Sellers and Raynier Devillier and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Boris Calmels

72 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Boris Calmels France	20	718	504	407	402	345	78	1.4k
Priscilla Yam United States	16	501 0.7×	537 1.1×	179 0.4×	352 0.9×	241 0.7×	26	1.3k
FG Schuening United States	18	525 0.7×	304 0.6×	252 0.6×	399 1.0×	192 0.6×	36	1.1k
Shinsuke Takagi Japan	17	808 1.1×	352 0.7×	447 1.1×	82 0.2×	397 1.2×	71	1.3k
F. García‐Sánchez Spain	17	383 0.5×	219 0.4×	218 0.5×	138 0.3×	420 1.2×	119	1000
AP Gillio United States	12	1.1k 1.6×	463 0.9×	617 1.5×	518 1.3×	818 2.4×	14	2.0k
Satoko Morishima Japan	21	566 0.8×	207 0.4×	233 0.6×	86 0.2×	665 1.9×	71	1.2k
A Zander Germany	17	465 0.6×	317 0.6×	420 1.0×	131 0.3×	273 0.8×	51	1.1k
Antonio Jiménez United States	17	428 0.6×	327 0.6×	254 0.6×	80 0.2×	148 0.4×	59	944
Lutz Uharek Germany	20	595 0.8×	266 0.5×	448 1.1×	71 0.2×	777 2.3×	72	1.3k
Dominik Schneidawind Germany	21	519 0.7×	430 0.9×	303 0.7×	60 0.1×	609 1.8×	57	1.2k

Countries citing papers authored by Boris Calmels

Since Specialization

Citations

This map shows the geographic impact of Boris Calmels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Calmels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Calmels more than expected).

Fields of papers citing papers by Boris Calmels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Calmels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Calmels. The network helps show where Boris Calmels may publish in the future.

Co-authorship network of co-authors of Boris Calmels

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Calmels. A scholar is included among the top collaborators of Boris Calmels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Calmels. Boris Calmels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ballot, Caroline, Xavier Lafarge, Fabrice H.F. Pierre, et al.. (2025). L’après-COBE2991® : quelles options pour la préparation des greffons de cellules souches hématopoïétiques (cellules souches périphériques autologues et allogéniques, allogreffes de moelle osseuse) ? (SFGM-TC). Bulletin du Cancer.

Fürst, Sabine, Boris Calmels, Thomas Pagliardini, et al.. (2023). GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 58(11). 1179–1181. 2 indexed citations

Garciaz, Sylvain, Angéla Granata, Boris Calmels, et al.. (2020). Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF. PLoS ONE. 15(3). e0228878–e0228878. 4 indexed citations

Mfarrej, Bechara, et al.. (2020). Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products. Cytotherapy. 23(1). 77–87. 8 indexed citations

Chabannon, Christian, Réda Bouabdallah, S. Fürst, et al.. (2019). CAR-T cells : lymphocytes exprimant un récepteur chimérique à l’antigène. La Revue de Médecine Interne. 40(8). 545–552. 2 indexed citations

Vos, John De, Étienne Baudoux, Jacques‐Olivier Bay, et al.. (2018). Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 106(1). S35–S39. 11 indexed citations

Pagliardini, Thomas, Samia Harbi, Sabine Fürst, et al.. (2018). Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients. Bone Marrow Transplantation. 54(7). 1067–1076. 19 indexed citations

Bramanti, Stéfania, Samia Harbi, Sabine Fürst, et al.. (2017). Killer Cell Immunoglobulin-Like Receptor–Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell–Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide. Biology of Blood and Marrow Transplantation. 24(3). 549–554. 39 indexed citations

Granata, Angéla, et al.. (2016). An intra-patient comparison of blood cell separators Spectra and Optia in patients and donors undergoing blood mononuclear cell collections at a single institution for subsequent autologous or allogeneic hematopoietic cell transplantation reveals comparable collection efficiencies. Bone Marrow Transplantation. 51(7). 1007–1009. 9 indexed citations

10.

Devillier, Raynier, Sabine Fürst, Roberto Crocchiolo, et al.. (2014). Poor Outcome with Nonmyeloablative Conditioning Regimen before Cord Blood Transplantation for Patients with High-Risk Acute Myeloid Leukemia Compared with Matched Related or Unrelated Donor Transplantation. Biology of Blood and Marrow Transplantation. 20(10). 1560–1565. 8 indexed citations

11.

Klyuchnikov, Evgeny, Jean El Cheikh, Andreas Sputtek, et al.. (2013). CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies. Biology of Blood and Marrow Transplantation. 20(3). 382–386. 67 indexed citations

12.

Cheikh, Jean El, Roberto Crocchiolo, Sabine Fürst, et al.. (2012). Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. American Journal of Hematology. 87(12). 1074–1078. 18 indexed citations

13.

Cheikh, Jean El, Boris Calmels, Claude Lemarié, et al.. (2011). Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma. Hematology/Oncology and Stem Cell Therapy. 4(1). 30–36. 25 indexed citations

14.

Spicuglia, Salvatore, Christelle Vincent‐Fabert, Touati Benoukraf, et al.. (2011). Characterisation of Genome-Wide PLZF/RARA Target Genes. PLoS ONE. 6(9). e24176–e24176. 18 indexed citations

15.

Chabannon, Christian, et al.. (2011). La mobilisation des progéniteurs hématopoïétiques : nouvelles cibles et nouvelles modalités thérapeutiques. Bulletin du Cancer. 98(8). 951–961. 2 indexed citations

16.

Barlogis, Vincent, Claude Lemarié, Claire Galambrun, et al.. (2010). Impact of Viable CD45 Cells Infused on Lymphocyte Subset Recovery after Unrelated Cord Blood Transplantation in Children. Biology of Blood and Marrow Transplantation. 17(1). 109–116. 5 indexed citations

17.

Lemarié, Claude, et al.. (2009). A new single-platform method for the enumeration of CD34+ cells. Cytotherapy. 11(6). 804–806. 7 indexed citations

18.

Moreau, Thomas, Boris Calmels, Vincent Barlogis, et al.. (2007). Potential Application of Gene Therapy to X-Linked Agammaglobulinemia. Current Gene Therapy. 7(4). 284–294. 10 indexed citations

19.

Lemarié, Claude, Boris Calmels, Didier Blaise, et al.. (2005). Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate. Transfusion. 45(5). 737–742. 35 indexed citations

20.

Mohty, Mohamad, Béatrice Gaugler, Boris Calmels, et al.. (2003). Immunothérapie des leucémies aiguës myéloïdes : développement d‘approches vaccinales utilisant des cellules dendritiques dérivées de blastes leucémiques. Bulletin du Cancer. 90(8). 751–757. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact